Patient Guide: A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 51 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07083739
Status: NOT_YET_RECRUITING
Condition: Primary Immune Thrombocytopenia
Phase: PHASE2

Where You Can Participate

This study is available at 51 locations across the country.

Top locations include:
  • • Hefei, Anhui
  • • Wuhu, Anhui
  • • Beijing, Beijing
  • • And 48 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults - Join Clinical Trial NCTNCT07083739

How to Join This Clinical Trial - NCTNCT07083739

Learn how to participate in this PHASE2 trial studying an investigational therapy for Primary Immune Thrombocytopenia. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Primary Immune Thrombocytopenia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Primary Immune Thrombocytopenia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07083739 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 51 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230001 - China

Status: Contact for availability

Clinical Research Site

Wuhu, Anhui 241001 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing 100020 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing 100730 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing 400010 - China

Status: Contact for availability

Clinical Research Site

Lanzhou, Gansu 730000 - China

Status: Contact for availability

Clinical Research Site

Guangzhou, Guangdong 510515 - China

Status: Contact for availability

Clinical Research Site

Shenzhen, Guangdong 518000 - China

Status: Contact for availability

Clinical Research Site

Zhanjiang, Guangdong 524045 - China

Status: Contact for availability

Clinical Research Site

Nanning, Guangxi 530005 - China

Status: Contact for availability

And 41 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Primary Immune Thrombocytopenia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships